146 related articles for article (PubMed ID: 2232266)
1. [Quantitative estimation of malignancy of gastric cancer by DNA ploidy and proliferative activities].
Yonemura Y; Miyazaki I
Rinsho Byori; 1990 Sep; 38(9):1053-8. PubMed ID: 2232266
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.
Yonemura Y; Ooyama S; Sugiyama K; Kamata T; De Aretxabala X; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Cancer Res; 1990 Feb; 50(3):509-14. PubMed ID: 2297693
[TBL] [Abstract][Full Text] [Related]
3. [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity].
Yonemura Y; Sugiyama K; Kamata T; Fujimura T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1175-80. PubMed ID: 3054478
[TBL] [Abstract][Full Text] [Related]
4. Relation of proliferative activity to survival in patients with advanced gastric cancer.
Yonemura Y; Kamata T; Ohoyama S; Matumoto H; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Anal Cell Pathol; 1991 Mar; 3(2):103-10. PubMed ID: 2025600
[TBL] [Abstract][Full Text] [Related]
5. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
[TBL] [Abstract][Full Text] [Related]
7. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.
Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
Anticancer Res; 1997; 17(4B):2923-6. PubMed ID: 9329565
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
[TBL] [Abstract][Full Text] [Related]
9. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S
Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy is a major prognostic factor in advanced gastric carcinoma--univariate and multivariate analysis.
Haraguchi M; Watanabe A; Moriguchi S; Korenaga D; Maehara Y; Okamura T; Sugimachi K
Surgery; 1991 Nov; 110(5):814-9. PubMed ID: 1948649
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric DNA analysis of gastric cancer that is invading the muscularis propria.
Mizunuma H; Tsuchiya A; Ando Y; Kikuchi Y; Abe R
Eur J Surg; 1996 Nov; 162(11):889-94. PubMed ID: 8956958
[TBL] [Abstract][Full Text] [Related]
13. [Proliferative activity as a marker for lymph node metastases on early gastric cancers--in vitro bromodeoxyuridine labeling for clinical use].
Ohyama S; Yonemura Y; Kamata T; Kosaka T; Yamaguchi A; Kouichi ; Miwa ; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):354-9. PubMed ID: 2359392
[TBL] [Abstract][Full Text] [Related]
14. [DNA index as a significant prognostic indicator of colorectal cancer].
Kimura O; Sugamura K; Kijima T; Kurayoshi K; Makino M; Kaibara N
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():118-24. PubMed ID: 8678553
[TBL] [Abstract][Full Text] [Related]
15. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between the expression of urokinase-type plasminogen activator, E-cadherin and malignancy in gastric cancer].
Itoh H; Yonemura Y; Tsuchihara K; Kawamura T; Nojima N; Kaji M; Fushida S; Nishimura G; Fujimura T; Miwa K
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():124-9. PubMed ID: 7611774
[TBL] [Abstract][Full Text] [Related]
17. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
[TBL] [Abstract][Full Text] [Related]
18. Correlation of DNA ploidy and proliferative activity in human gastric cancer.
Yonemura Y; Sugiyama K; Fujimura T; De Aretxabala X; Kamata T; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Cancer; 1988 Oct; 62(8):1497-502. PubMed ID: 3167767
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of DNA ploidy in breast cancer stage I-II.
Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
[TBL] [Abstract][Full Text] [Related]
20. [DNA ploidy pattern as an indicator of degree of malignancy and prognosis in gastric cancer].
Kitamura M; Arai K; Miyashita K; Takahashi K; Kato H; Takamoto S; Maeda Y
Nihon Rinsho; 1992 Oct; 50(10):2401-7. PubMed ID: 1447810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
